ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Experience
Instructional Level
Credit(s): PDHs: 4.0, ASHA CEUs*: 0.4
Summary: These SIG 12 Perspectives articles provide information on current issues associated with display design and image complexity for individuals with cortical visual impairment and an in-depth overview of telepractice for people who rely on augmentative and alternative communication. Readers will be more adept at assessing and assisting children with cortical visual impairment and will have a better understanding of telepractice methods that can be used to improve virtual service delivery.
Credit(s): PDHs: 1.5, ASHA CEUs*: 0.15
Summary: This Perspectives activity highlights two articles with objective measures for both evaluation and treatment of velopharyngeal dysfunction. The first article discusses the palatal closure efficiency (PaCE) index. This is an aerodynamic tool used to estimate the velopharyngeal opening during certain speech contexts. This is done by measuring a percentage of change between nasal and oral cognates of an individual. The second article describes the nasometer in depth, highlighting its use as an evaluation and treatment tool for decreasing hypernasality. It goes into further detail on the differences between hypernasality and measured nasalance, highlighting both strengths and limitations of the nasalance score.
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: The article in this SIG 6 activity focuses on the audiologic variations seen among patients undergoing the same type of ototoxic drug treatment (cisplatin). Results show a large amount of audiologic outcome variability among the two patients examined, despite similar demographic factors, drug treatments, and types of cancer. Factors relating to ototoxic susceptibility are discussed, and the importance of otoxicity monitoring programs for early detection of audiologic change is highlighted.
Credit(s): PDHs: 3.5, ASHA CEUs*: 0.35
Summary: This SIG 5 activity analyzes the relationship between the opioid crisis and cleft lip and palate care across the life span. Two main themes of prevention and treatment after exposure are explained. The articles outline alternatives to opioid use after cleft-related surgeries, impacts on infants and children who were exposed in utero, and velopharyngeal insufficiency treatment after substance abuse.
Credit(s): PDHs: 3.5, ASHA CEUs*: 0.35
Summary: These SIG 12 Perspectives articles provide information on current issues associated with visual processing of augmentative and alternative communication (AAC) displays for people with traumatic brain injury, assessment of the expressive language abilities of Spanish-speaking children who rely on AAC, and culturally sensitive approaches to aided language modeling. Readers will be more adept at designing effective AAC displays for adults with traumatic brain injury and at providing AAC services to children from multilingual and multicultural backgrounds.
Credit(s): PDHs: 3.0, ASHA CEUs*: 0.3
Summary: These three articles describe current issues and advances related to hearing diagnostics, treatment, and prevention. The first article is a detailed description of the impact that COVID-19 face masks and social distancing regulations have had on speech recognition and how face masks affect the acoustic signal and increase cognitive effort in listeners with hearing loss. Suggestions for mitigating these deleterious impacts on communication are provided. The second article is a research study examining the correlation between self-perceived hearing difficulty, determined using a questionnaire (Adult Auditory Performance Scale), and speech-in-noise performance (Listening in Spatialized Noise–Sentences Test) in listeners with normal pure-tone thresholds. Results highlight the relationship between self-perceived hearing abilities and binaural speech-in-noise performance supporting the inclusion of speech-in-noise testing even in those with normal pure-tone thresholds. The third article is a review of current genetic, stem cell, and pharmacotherapy research for treatment and prevention of hearing loss. Animal models are discussed, as well as steps to translate this research into clinical practice.